VeriChip(TM) Announces Results of Italian National Institute Two-Year Clinical Study of VeriMed System
November 30 2006 - 7:30AM
PR Newswire (US)
Study Reports Full Patient Acceptance and Flawless Data Retrieval
with No Complications DELRAY BEACH, Fla., Nov. 30
/PRNewswire-FirstCall/ -- Applied Digital Solutions (NASDAQ:ADSX),
though its subsidiary VeriChip Corporation, announced today the
results of a clinical study on its VeriMed System for patient radio
frequency identification (RFID) conducted by the Spallanzi National
Institute of Rome Italy and sponsored by the Italian Ministry of
Health. The two-year, 10 patient study was designed to evaluate the
safety and efficacy of the VeriMed implantable RFID microchip and
the functionality of the VeriMed System in the management of
patients with chronic infectious diseases undergoing care at the
Institute. The study reported no complications or side effects
related to the insertion procedure, flawless access of the ID
number using the hand-held reader, and universal acceptance within
the patient study group. Based on the results of the study, the
exclusive VeriChip distributor for Italy plans to petition the
Italian Ministry of Health for full availability of the VeriMed
System through the Italian National Health Service. Richard Seelig,
MD, Vice President, Medical Applications of VeriChip Corporation
commented, "We are extremely pleased with the results of the first
long-term clinical study evaluating all aspects of the VeriMed
System in a clinical management environment. The findings confirm
that the VeriMed System provides a favorable clinical utility to
treating physicians. The study also demonstrates the appeal of
VeriMed to the patient population as all participants in the study
elected to retain their VeriChip implant for use beyond the
conclusion of the study." Mr. Giorgio Fanara, President of Fanara
& Associati, who proposed and followed every step and aspect of
the Italian study commented: "We would like to express our great
satisfaction as now in Italy there is a system capable of meeting
and satisfying the universal availability of patient clinical
information and guarantee the security of the medical record. I
would like to thank Doctor Giorgio Antonucci, Scientific Research
Director of the Spallanzi National Institute and all his staff for
their high professional skills and great work during these years."
About VeriChip Corporation VeriChip Corporation, headquartered in
Delray Beach, Florida, develops, markets and sells radio frequency
identification, or RFID, systems used to identify, locate and
protect people and assets. VeriChip's goal is to become the leading
provider of RFID systems for people in the healthcare industry.
VeriChip sells passive RFID systems for identification purposes and
active RFID systems for local-area location and identification
purposes. VeriChip recently began to market its VeriMed(TM) Patient
Identification System for rapidly and accurately identifying people
who arrive in an emergency room and are unable to communicate. This
system uses the first human-implantable passive RFID microchip, the
implantable VeriChip(TM), cleared for medical use in October 2004
by the United States Food and Drug Administration. For more
information on VeriChip, please call 1-800-970-2447, or email .
Additional information can be found online at
http://www.verichipcorp.com/. About Applied Digital - "The Power of
Identification Technology" Applied Digital develops innovative
identification and security products for consumer, commercial, and
government sectors worldwide. The Company's unique and often
proprietary products provide identification and security systems
for people, animals, the food supply, government/military arena,
and commercial assets. Included in this diversified product line
are RFID applications, end-to-end food safety systems,
GPS/Satellite communications, and telecomm and security
infrastructure, positioning Applied Digital as the leader in
identification technology. Applied Digital is the owner of a
majority position in Digital Angel Corporation (AMEX:DOC).
Statements about the Company's future expectations, including
future revenues and earnings, and all other statements in this
press release other than historical facts are "forward-looking
statements" within the meaning of Section 27A of the Securities Act
of 1933, Section 21E of the Securities Exchange Act of 1934, and as
that term is defined in the Private Litigation Reform Act of 1995.
Such forward-looking statements involve risks and uncertainties and
are subject to change at any time, and the Company's actual results
could differ materially from expected results. The Company
undertakes no obligation to update forward-looking statements to
reflect subsequently occurring events or circumstances. Contact:
Investors: Nick Laudico The Ruth Group 646-536-7030 Media: Jason
Rando The Ruth Group 646-536-7025 DATASOURCE: Applied Digital
Solutions CONTACT: Investors: Nick Laudico, +1-646-536-7030, , or
Media: Jason Rando, +1-646-536-7025, , both of The Ruth Group Web
site: http://www.verichipcorp.com/
Copyright
Applied Digital Solutions (NASDAQ:ADSX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Applied Digital Solutions (NASDAQ:ADSX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Applied Digital Solutions (MM) (NASDAQ): 0 recent articles
More Applied Digital Solutions (MM) News Articles